I'm just wondering something probably very stupid. Shouldn't an FOIA request turn back all information that the article claims the FDA is refusing to give away ?
Looking at the FDA FOIA exemption list (
http://www.fda.gov/RegulatoryInformation/FOI/ucm390370.htm or
http://www.foia.gov/faq.html#exemptions), there's none that seems to match a drug name, a lab's name, a detail on a mistake or even communication between ab and FDA. The only things that I would think apply would be internal FDA comm, and patient names.
None of the things I cited sound like :
- national security threats
- internal rules
- breaking federal law
- trade secrets, commercial or financial info
- inter/intra agency comm
- personal privacy (if we exclude patient names)
- law enforcement info
- supervision of financial institutions (that's an interesting exception to see BTW)
- geological info on wells (totally off topic, but I'm kind of curious about this one).
It looks like the author si as baffled by the assumption that misconduct fall into the "commercial info" exception...
Really scary also is the whole orange book thing. I thought generics were actually the exact same molecule, as in "we've done a mass spectrometry of the stuff, and it's the same shit, only cheaper". It looks it's not at all the case... Reading the wikipedia talks on generic drugs, it looks like there was confusion there as well (http://en.wikipedia.org/wiki/Talk%3AGeneric_drug#Orange_book). As of today, there's only one reference to the word molecule in the wikipedia article ("[...] most small molecule drugs are accepted as bioequivalent if[...]), which doesn't seem to address the confusion.
Assuming (and it's a pretty big assumption) that insurances really want you to get better, it would then look like the should tell you _not_ to use generics, rather than pushing you to. Argument could be made that you only depend on them for a limited time. I guess the same argument could be made for public healthcare systems (like France), in the sense that you're less expensive dead on generics than alive on the real stuff, but I sound a bit cynical, even to myself.